mirtazapine has been researched along with Idiopathic Pulmonary Fibrosis in 1 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Idiopathic Pulmonary Fibrosis: A common interstitial lung disease of unknown etiology, usually occurring between 50-70 years of age. Clinically, it is characterized by an insidious onset of breathlessness with exertion and a nonproductive cough, leading to progressive DYSPNEA. Pathological features show scant interstitial inflammation, patchy collagen fibrosis, prominent fibroblast proliferation foci, and microscopic honeycomb change.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelhady, R | 1 |
| Cavalu, S | 1 |
| Saber, S | 1 |
| Elmowafy, R | 1 |
| Morsy, NE | 1 |
| Ibrahim, S | 1 |
| Abdeldaiem, MSI | 1 |
| Samy, M | 1 |
| Abd-Eldayem, MA | 1 |
| Shata, A | 1 |
| Elgharabawy, RM | 1 |
1 other study available for mirtazapine and Idiopathic Pulmonary Fibrosis
| Article | Year |
|---|---|
Mirtazapine, an atypical antidepressant, mitigates lung fibrosis by suppressing NLPR3 inflammasome and fibrosis-related mediators in endotracheal bleomycin rat model.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Bleomycin; Fibrosis; Idiop | 2023 |